CellCentric's Series A Round

CellCentric raised a round of funding on October 22, 2007.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Series A Round: